Tempus
PROVIDERS
LIFE SCIENCES
PATIENTS
OUR PLATFORM
ORDER A TEST
Log In
Contact Us
Menu
Tempus
ORDER A TEST
Log In
Contact Us
Providers
Oncology
Neurology & Psychiatry
Infectious Disease
Cardiology
Academic & Research
EMR Integration
Life Sciences
Sequencing
Companion Diagnostics
Clinical Trial Solutions
Data Collaborations
AI Applications
Biological Modeling
Patients
Oncology Patients
Neurology Patients
Infectious Disease Patients
Our Platform
Genomic Profiling
Clinical Trial Matching
Companion Diagnostics
Multi-Omics
Tempus ONE
Infectious Disease
About Us
Our Team
Careers
Culture
Resources
Publications
News
Blog
Resources
Publications
Keyword search
Filter By
Oncology
Infectious Disease
Cardiology
Neuro/Psych
12/21/2021
Oncology
Validation of Genomic and Transcriptomic Models of Homologous Recombination Deficiency in a Real-World Pan-Cancer Cohort
12/07/2021
Oncology
Multi-omic Profiling of Simultaneous Ductal Carcinoma In Situ and Invasive Breast Cancer
12/07/2021
Oncology
Loss of ASXL1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors in ER+ Breast Cancer
12/07/2021
Oncology
The Frequency and Somatic Mutation Landscape of Fibroblast Growth Factor Receptor (FGFR) Alterations in Breast Cancer
12/07/2021
Oncology
Mouse-INtraDuctal (MIND): An In Vivo Model for Studying the Underlying Mechanisms of DCIS Malignancy
12/07/2021
Oncology
Genomic Landscape of HER2-Negative Advanced or Metastatic Breast Cancer with PIK3CA Gain-of-Function Mutations
12/07/2021
Oncology
A Platform of CDK4/6 Inhibitor-Resistant Patient-Derived Breast Cancer Organoids Illuminates Mechanisms of Resistance and Therapeutic Vulnerabilities
12/07/2021
Oncology
Preclinical Activity of KB-0742, an Oral, Highly Selective, CDK9 Inhibitor, in Cell Lines and in MYC-High Expressing, Patient-Derived Models of Multiple Breast Cancer Subtypes
12/07/2021
Oncology
Comprehensive Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma (ILC): Using Real-World Data to Describe this Unique Clinical Entity
12/07/2021
Oncology
The Genomic and Transcriptomic Landscape of PIK3R1-Mutated Breast Cancers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21